Wait for pullback to 10 EMA at 576 or 20 SMA at 553 before initiating; reduce initial tranche to 25 percent of intended weight at current levels; tighten stop to 558 (just below 10 EMA); reserve adds for confirmed retest of 20 SMA at 553 or below.

• ATR peaked at 17.13 on July 24, fell to 15.36 over 10 consecutive sessions—10 percent volatility decline during price advance signals exhaustion rather than accumulation
• 82 percent volume contraction from 3.27 million share day to 578,000 is a bearish divergence, not 'digestion'—absence of follow-through demand contradicts institutional accumulation thesis
• Golden cross at 10 trading days old is tentative, not confirmed regime; 50 SMA at 534 remains below 200 SMA at 542 in absolute terms; slope crossovers fail regularly after sharp rallies
• RSI at 65.93 after moving from 30s to 66 in six weeks is dynamic overextension despite static threshold; with 0.11 beta, this represents unusual momentum for a defensive name
• Risk-reward asymmetry overstated: stop at 542 faces daily ranges of 15.36 ATR with likely slippage; realistic drawdown exceeds stated 7.7 percent; low-end Street target at 590 is 0.3 percent above current price of 587.95
• EBITDA declined from 10.44 billion (2023 peak) to 8.73 billion despite revenue growth from 67.57 billion to 75.05 billion—16 percent margin compression on 11 percent revenue increase
• Q2 sequential 23 percent growth is normal seasonality from fiscal year-end budget flush, not acceleration; FCF rebound of 30 percent came off depressed 2024 base; absolute FCF of 6.91 billion still below normalized 2022 level
• Sentiment score of 6.2 out of 10 with low confidence and incomplete data (StockTwits error, Reddit silence) is an unknown risk, not confirmation that crowd hasn't caught up
• Name already returned 18.56 percent year to date; adding above-benchmark weight at upper Bollinger envelope locks in others' gains at momentum peak
• Iran-Hormuz détente reduces defense urgency premium; FRED macro gap means rate-path assumptions lack confirmation; P/E of 21.7x offers limited multiple compression cushion
• 0.11 beta and 2.37 percent dividend yield characterize a defensive name—chasing momentum in a defensive is a category error; upside in low-beta names is slow and muted, making the 14 percent run an outlier, not baseline

→ vs aggressive: ATR compression does not equal institutional accumulation—it signals volatility impulse exhaustion after sharp thrust, with 10 percent decline in 10 sessions while price holds near highs preceding pullback/consolidation more often than continuation

→ vs aggressive: 82 percent volume contraction is not a sign the 'big days did their job'—it's one of the strongest bearish divergences in classical technical analysis; no follow-through demand after breakout contradicts accumulation thesis

→ vs aggressive: Golden cross treated as 10-month confirmed regime when it's only 10 trading days old; 50 SMA at 534 still below 200 SMA at 542; treating slope event as structural event is premature

→ vs aggressive: RSI 65.93 'still five points below overbought' ignores dynamic context—steep ramp from 30s to 66 in six weeks is overextension relative to recent history, not 'room to run'

→ vs aggressive: Risk-reward framing uses 7.7 percent loss against 10-19 percent gain, but ATR of 15.36 means stops will be exceeded intraday; realistic loss exceeds stated risk; also, current price of 587.95 makes low-end Street target of 590 only 0.3 percent upside, tightening asymmetry significantly

→ vs aggressive: Fundamentals described as 'accelerating' when Q2 growth is normal seasonality and EBITDA margin compression of 16 percent over two years contradicts quality compounder narrative

→ vs aggressive: Incomplete sentiment data (StockTwits error, Reddit silence) treated as reassuring 'crowd hasn't caught up' when absence of retail confirmation in an 18.56 percent YTD gainer could indicate smart money has already distributed

→ vs aggressive: Macro headwinds dismissed as 'mildly bearish'—Iran-Hormuz détente reduces defense urgency premium, material at 21.7x P/E with limited margin of safety

→ vs aggressive: Position sizing endorsed as 'moderately above-benchmark' in name that has run 18.56 percent YTD and sits in upper Bollinger envelope—this concentrates risk at momentum peak rather than accumulating at better entry

BUY

• Current volume contraction (578,000 against 3.27M spike) represents digestion phase in equilibrium, not exhaustion or distribution
• Golden cross occurred but is only 10 trading days old with 50 SMA at 534 still below 200 SMA at 542 in absolute level — regime change is real but untested
• RSI of 65.93 in a 0.11 beta stock represents upper end of normal operating range, not coiled spring — limits upside but doesn't signal imminent reversal
• Risk-reward asymmetry is tighter than aggressive frames: realistic 8-10% downside vs 8-12% upside expected value rather than 7.7% vs 10-19%
• Conservative's 558 stop is too tight — will get clipped on normal pullback to 10 EMA at 576 where analyst wants to add; 542 stop below 200 SMA is structurally correct
• Conservative lands best fundamental punch: EBITDA peaked at 10.44 billion in 2023, declined to 8.73 billion in 2025 despite 11% revenue growth — 16% margin compression on 11% larger base
• Aggressive's Q2 2026 EPS of 7.94 distorted by Q2 2025 pension charge; sequential Q1-Q2 jump is seasonal fiscal year-end budget flush, not secular acceleration
• Q2 2026 operating margin of 12.4% is encouraging but one quarter does not reverse two-year margin trough; need confirmation
• Sentiment at 6.2/10 with low confidence and StockTwits/Reddit data outage means no information, not bullish or bearish signal — argues for modest sizing
• Iran-Hormuz de-escalation is single biggest threat to defense multiples; could cause 5-10% multiple compression separate from company-specific issues
• Recommended entry: 33-40% initial tranche on pullback to 565-580 zone; adds only on confirmed pullback to support, not chasing strength
• Recommended position sizing: benchmark weight or modestly above, not aggressively above-benchmark given extended technicals and incomplete sentiment data
• Aggressive's 50% initial tranche too aggressive for setup: already up 18.56% YTD, 14% in three weeks, upper third of Bollinger envelope, thin volume, incomplete sentiment
• 0.11 beta and 2.37% dividend yield provide patience premium — no urgency to full-load here

→ vs aggressive: Thin volume at highs does not prove institutional accumulation — equally valid explanation is institutional distribution into thin retail bid; aggressive treats absence of selling pressure as evidence of buying pressure, which is logical error

→ vs aggressive: EBITDA compression ignored entirely: peaked at 10.44 billion in 2023, declined to 8.73 billion in 2025 despite 11% revenue growth — 16% margin compression that fundamentally undermines the bull case

→ vs aggressive: Risk-reward framing is intellectually dishonest: 542 stop is ~3 ATRs away in a name that just ran 14% in three weeks, meaning realistic asymmetry is 8-10% vs 8-12%, not 7.7% vs 10-19%

→ vs aggressive: Iran-Hormuz de-escalation tail risk (5-10% multiple compression) treated as negligible but is single biggest threat to defense multiples right now

→ vs aggressive: Sentiment reading of 6.2/10 with low confidence and data outage is not bullish confirmation — absence of bearishness is not evidence of bullishness

→ vs conservative: 82% volume contraction interpreted as exhaustion is too clean — represents digestion phase in equilibrium, not bearish divergence

→ vs conservative: Golden cross framing dismissed too quickly; while young and untested, regime has flipped bullish and treating it as non-event underweights the structural shift

→ vs conservative: 558 stop is functionally broken: will trigger on normal pullback to 10 EMA at 576 where analyst wants to add — stops you out precisely where you'd want to accumulate

→ vs conservative: HOLD recommendation and waiting for 20 SMA at 553 will leave significant money on table if next leg begins from current levels

→ vs conservative: 25% initial tranche is too cautious given confirmed regime change; misses asymmetry opportunity when fundamentals are genuinely strong and technicals have flipped bullish